[Psoriasis arthropathica].
BACKGROUND
Five to seven percent of patients with psoriasis suffer additionally from accompanying arthritis.


OBJECTIVE
In this article, we review the current knowledge on clinical, diagnostic and therapeutic aspects of the disease.


RESULTS
Data are presented on the treatment of six patients with the immunosuppressant ciclosporin. Therapeutic results with this drug are superior to agents traditionally used for management of psoriatic arthritis.


CONCLUSIONS
The therapeutic options have been enlarged by the introduction of new immunosuppressive drugs, particularly ciclosporin.
Ruzicka
T
T
Cliniques Dermatologiques, l'Université Louis-Maximilien de Munich, Allemagne.
Arenberger
P
P
Wagner
S
S
Peter
R U
RU
Kemeny
L
L
D000293:Adolescent; D000328:Adult; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006229:Hand Dermatoses / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D012446:Sacroiliac Joint; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy
D016572:Cyclosporine
Psoriasis arthropathique.